Rou‐Ling Cho

404 total citations
16 papers, 356 citations indexed

About

Rou‐Ling Cho is a scholar working on Molecular Biology, Critical Care and Intensive Care Medicine and Immunology. According to data from OpenAlex, Rou‐Ling Cho has authored 16 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Critical Care and Intensive Care Medicine and 4 papers in Immunology. Recurrent topics in Rou‐Ling Cho's work include Heme Oxygenase-1 and Carbon Monoxide (8 papers), Thermal Regulation in Medicine (4 papers) and Immune Response and Inflammation (4 papers). Rou‐Ling Cho is often cited by papers focused on Heme Oxygenase-1 and Carbon Monoxide (8 papers), Thermal Regulation in Medicine (4 papers) and Immune Response and Inflammation (4 papers). Rou‐Ling Cho collaborates with scholars based in Taiwan and United States. Rou‐Ling Cho's co-authors include Chuen‐Mao Yang, Li‐Der Hsiao, Chih‐Chung Lin, Chien-Chung Yang, Chih‐Chung Lin, Wei‐Ning Lin, Hui‐Ching Tseng, Chih‐Chung Lin, Chen-Yu Wang and I‐Te Lee and has published in prestigious journals such as International Journal of Molecular Sciences, British Journal of Pharmacology and Biochemical Pharmacology.

In The Last Decade

Rou‐Ling Cho

14 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rou‐Ling Cho Taiwan 12 213 72 43 39 37 16 356
Irvith M. Carvajal United States 10 228 1.1× 93 1.3× 53 1.2× 58 1.5× 46 1.2× 13 419
Stepan B. Melnyk United States 16 195 0.9× 54 0.8× 32 0.7× 34 0.9× 84 2.3× 25 551
Harrison M. Penrose United States 12 220 1.0× 59 0.8× 55 1.3× 42 1.1× 60 1.6× 22 473
Xiaoqin Luo China 10 189 0.9× 106 1.5× 68 1.6× 68 1.7× 18 0.5× 20 415
Hongxia Mei China 14 134 0.6× 122 1.7× 54 1.3× 69 1.8× 37 1.0× 19 377
Samantha D. Pauls Canada 10 153 0.7× 100 1.4× 94 2.2× 19 0.5× 64 1.7× 17 416
Rafael I. Jaén Spain 9 135 0.6× 83 1.2× 17 0.4× 19 0.5× 27 0.7× 12 297
Xiaoyan Min China 8 222 1.0× 78 1.1× 16 0.4× 23 0.6× 35 0.9× 16 398
Zili Zhang China 10 206 1.0× 93 1.3× 18 0.4× 35 0.9× 20 0.5× 25 364

Countries citing papers authored by Rou‐Ling Cho

Since Specialization
Citations

This map shows the geographic impact of Rou‐Ling Cho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rou‐Ling Cho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rou‐Ling Cho more than expected).

Fields of papers citing papers by Rou‐Ling Cho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rou‐Ling Cho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rou‐Ling Cho. The network helps show where Rou‐Ling Cho may publish in the future.

Co-authorship network of co-authors of Rou‐Ling Cho

This figure shows the co-authorship network connecting the top 25 collaborators of Rou‐Ling Cho. A scholar is included among the top collaborators of Rou‐Ling Cho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rou‐Ling Cho. Rou‐Ling Cho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Cho, Rou‐Ling, Yu‐Lueng Shih, Pei‐Ju Lien, et al.. (2025). Nitroxoline upregulates low-density lipoprotein receptors expression, enhances lipid metabolism, and reduces hepatic steatosis and atherosclerosis in Apoe−/− mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(8). 168016–168016.
2.
Lin, Chin‐Sheng, Ching‐Yuh Chern, Rou‐Ling Cho, et al.. (2025). Chalcone derivative 1m mitigates hepatic fibrosis and inflammation, enhances cholesterol efflux and reduces atherosclerosis. International Immunopharmacology. 162. 115189–115189.
3.
Tsai, Min‐Chien, et al.. (2024). Cav3.1 T-type calcium channel blocker NNC 55-0396 reduces atherosclerosis by increasing cholesterol efflux. Biochemical Pharmacology. 222. 116096–116096. 3 indexed citations
4.
5.
Yang, Chuen‐Mao, Chih‐Chung Lin, Chien-Chung Yang, Rou‐Ling Cho, & Li‐Der Hsiao. (2020). Mevastatin-Induced AP-1-Dependent HO-1 Expression Suppresses Vascular Cell Adhesion Molecule-1 Expression and Monocyte Adhesion on Human Pulmonary Alveolar Epithelial Cells Challenged with TNF-α. Biomolecules. 10(3). 381–381. 15 indexed citations
6.
Anchoori, Ravi, et al.. (2020). Bis-benzylidine Piperidone RA190 treatment of hepatocellular carcinoma via binding RPN13 and inhibiting NF-κB signaling. BMC Cancer. 20(1). 386–386. 14 indexed citations
7.
Lin, Chih‐Chung, Wei‐Ning Lin, Rou‐Ling Cho, et al.. (2020). Induction of HO-1 by Mevastatin Mediated via a Nox/ROS-Dependent c-Src/PDGFRα/PI3K/Akt/Nrf2/ARE Cascade Suppresses TNF-α-Induced Lung Inflammation. Journal of Clinical Medicine. 9(1). 226–226. 25 indexed citations
8.
Lin, Chih‐Chung, Li‐Der Hsiao, Rou‐Ling Cho, & Chuen‐Mao Yang. (2019). CO-Releasing Molecule-2 Induces Nrf2/ARE-Dependent Heme Oxygenase-1 Expression Suppressing TNF-α-Induced Pulmonary Inflammation. Journal of Clinical Medicine. 8(4). 436–436. 20 indexed citations
9.
Lin, Chih‐Chung, Li‐Der Hsiao, Rou‐Ling Cho, & Chuen‐Mao Yang. (2019). Carbon Monoxide Releasing Molecule-2-Upregulated ROS-Dependent Heme Oxygenase-1 Axis Suppresses Lipopolysaccharide-Induced Airway Inflammation. International Journal of Molecular Sciences. 20(13). 3157–3157. 30 indexed citations
10.
11.
Cho, Rou‐Ling, Wei‐Ning Lin, Chen-Yu Wang, et al.. (2018). Heme oxygenase-1 induction by rosiglitazone via PKCα/AMPKα/p38 MAPKα/SIRT1/PPARγ pathway suppresses lipopolysaccharide-mediated pulmonary inflammation. Biochemical Pharmacology. 148. 222–237. 39 indexed citations
12.
Lin, Chih‐Chung, et al.. (2017). Up‐regulation of PYK2/PKCα‐dependent haem oxygenase‐1 by CO‐releasing molecule‐2 attenuates TNF‐α‐induced lung inflammation. British Journal of Pharmacology. 175(3). 456–468. 10 indexed citations
13.
Lin, Chih‐Chung, Wei‐Ning Lin, Rou‐Ling Cho, et al.. (2016). TNF-α-Induced cPLA2 Expression via NADPH Oxidase/Reactive Oxygen Species-Dependent NF-κB Cascade on Human Pulmonary Alveolar Epithelial Cells. Frontiers in Pharmacology. 7. 447–447. 23 indexed citations
14.
Lin, Chih‐Chung, Chien-Chung Yang, Rou‐Ling Cho, et al.. (2016). Sphingosine 1-Phosphate-Induced ICAM-1 Expression via NADPH Oxidase/ROS-Dependent NF-κB Cascade on Human Pulmonary Alveolar Epithelial Cells. Frontiers in Pharmacology. 7. 80–80. 18 indexed citations
15.
Cho, Rou‐Ling, I‐Te Lee, Chih‐Chung Lin, et al.. (2016). Lipopolysaccharide induces ICAM-1 expression via a c-Src/NADPH oxidase/ROS-dependent NF-κB pathway in human pulmonary alveolar epithelial cells. American Journal of Physiology-Lung Cellular and Molecular Physiology. 310(7). L639–L657. 66 indexed citations
16.
Lee, I‐Te, et al.. (2014). Resveratrol inhibitsStaphylococcus aureus-induced TLR2/MyD88/NF-κB-dependent VCAM-1 expression in human lung epithelial cells. Clinical Science. 127(6). 375–390. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Irvith M. Carvajal Breakdown of academic impact, for papers by Stepan B. Melnyk Breakdown of academic impact, for papers by Harrison M. Penrose Breakdown of academic impact, for papers by Xiaoqin Luo Breakdown of academic impact, for papers by Hongxia Mei Breakdown of academic impact, for papers by Samantha D. Pauls Breakdown of academic impact, for papers by Rafael I. Jaén Breakdown of academic impact, for papers by Xiaoyan Min Breakdown of academic impact, for papers by Zili Zhang
Rankless by CCL
2026